160 Participants Needed

Diet for Gulf War Syndrome

Recruiting at 3 trial locations
HT
KF
Overseen ByKathleen F Holton, PhD, MPH
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Pivotal Trial (Near Approval)This treatment is in the last trial phase before FDA approval
Prior Safety DataThis treatment has passed at least one previous human trial
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a special diet (dietary intervention) to see if it can improve symptoms for veterans with Gulf War Illness, a condition affecting those who served in the 1990-1991 Persian Gulf War. Researchers aim to confirm the diet's effectiveness in a larger group and understand its impact on the nervous system and blood markers. Participants will either start the diet or continue their usual eating habits for one month before reassessment. Veterans with stable medication routines who meet specific criteria for Gulf War Illness are ideal candidates for this trial. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants a chance to contribute to a potentially groundbreaking treatment.

Will I have to stop taking my current medications?

Participants must keep their current medications and supplements stable throughout the study. However, if you are taking medication that affects certain brain chemicals, you may need to work with your doctor to stop those before joining the trial.

Is there any evidence suggesting that this dietary intervention is likely to be safe?

Research has shown that the diet being tested for Gulf War Illness is safe. In earlier studies, veterans who tried this diet reported feeling better overall, with fewer symptoms, and some symptoms disappeared completely. Importantly, the diet was easy to follow, and participants did not report any serious side effects. This suggests the diet is likely safe for most people. Participants in those studies experienced less pain and tiredness without major negative effects. This evidence supports the diet's safety for those considering joining the trial.12345

Why do researchers think this study treatment might be promising for Gulf War Syndrome?

Researchers are excited about this dietary intervention for Gulf War Syndrome because it takes a whole new approach to managing the condition. Unlike typical treatments, which often focus on medication or therapy to manage symptoms, this approach involves a specific diet designed to alleviate symptoms. The focus on dietary change is significant because it empowers individuals to take control of their health with potentially fewer side effects than medications. Additionally, the intervention is accessible and can be integrated into daily life with proper guidance and preparation, offering a promising alternative for those seeking relief from Gulf War Syndrome symptoms.

What evidence suggests that this dietary intervention is effective for Gulf War Syndrome?

This trial will compare a dietary intervention with a waitlisted control group for people with Gulf War Illness. Research has shown that a specific diet, which participants in the Dietary Intervention Group will follow, can effectively manage symptoms. In an earlier study, individuals who followed this diet reported significant improvements, with an average of nine symptoms disappearing after just one month. The diet appears to help by affecting the nervous system, which might explain the symptom improvement. Overall, the evidence strongly suggests that this dietary change can effectively manage the condition.12367

Who Is on the Research Team?

KF

Kathleen F Holton, PhD, MPH

Principal Investigator

American University

Are You a Good Fit for This Trial?

This trial is for men and women up to 75 years old who served in the 1990-1991 Persian Gulf War and meet specific criteria for Gulf War Illness. They must have been on a stable medication regimen for at least one month and be willing to maintain it, as well as their supplement intake, without changes during the study.

Inclusion Criteria

Served in the 1990-1991 Persian Gulf War
I am 75 years old or younger.
My medications have been the same for over a month and I can keep them stable during the study.
See 1 more

Exclusion Criteria

Unwilling to stop using alcohol, tobacco (including vaping) and/or marijuana; or unwilling to change diet
Recent substance use disorder (past year)
I am on medication that affects brain signaling but can stop if needed.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Baseline measures are collected before randomization into intervention or control group

1 week
1 visit (in-person)

Dietary Intervention

Participants undergo a 2-hour training on the diet and follow it for 4 weeks

4 weeks
1 visit (virtual) for training

Control Period

Waitlisted control group follows usual diet for 1 month before reassessment

4 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Dietary Intervention
Trial Overview The trial is testing a dietary intervention that previously showed symptom improvement in veterans with Gulf War Illness. Participants will be split into two groups: one following the diet and another wait-listed control group. The study aims to confirm earlier results, understand nervous system changes due to the diet, and identify blood markers after one month.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Dietary Intervention GroupExperimental Treatment1 Intervention
Group II: Waitlisted Control GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

American University

Lead Sponsor

Trials
22
Recruited
5,600+

Boston University

Collaborator

Trials
494
Recruited
9,998,000+

Massachusetts General Hospital

Collaborator

Trials
3,066
Recruited
13,430,000+

Georgetown University

Collaborator

Trials
355
Recruited
142,000+

Nova Southeastern University

Collaborator

Trials
103
Recruited
12,000+

Published Research Related to This Trial

Approximately 70% of military personnel use dietary supplements, which is significantly higher than the 50% usage rate in the general civilian population, potentially increasing their risk of adverse events.
The US Department of Defense has implemented measures like Operation Supplement Safety to educate military personnel about safe supplement use and to monitor and report adverse events associated with dietary supplements.
Protecting military personnel from high risk dietary supplements.Deuster, PA., Lieberman, HR.[2017]
In a study of 256 women, those receiving interdisciplinary therapy showed significantly better adherence to follow-up check-ups (78.44%) compared to those on diet alone (50.65%), indicating that interdisciplinary approaches may enhance patient engagement.
After 8 weeks, the interdisciplinary therapy group lost an average of 5.88 kg, while the diet-only group lost 4.18 kg, suggesting that a comprehensive treatment approach may lead to greater weight loss outcomes.
Interdisciplinary treatment of a female outpatient population. Organizational model and preliminary results.Boschi, V., Siervo, M., Nasti, G., et al.[2019]
A systematic review of 35 studies on dietary interventions for military veterans showed that these interventions primarily target overweight/obesity and chronic diseases, with a focus on weight loss as the main outcome.
While dietary interventions demonstrated moderate success in improving health outcomes, challenges such as poor compliance and high dropout rates highlight the need for better-tailored programs to address the unique needs of veterans.
Scope of Use and Effectiveness of Dietary Interventions for Improving Health-Related Outcomes in Veterans: A Systematic Review.Mellor, R., Saunders-Dow, E., Mayr, HL.[2022]

Citations

Results - Gulf War Illness: A Systematic Review of ... - NCBISummary of the effectiveness and strength of evidence from placebo-controlled trials of nutritional supplements for treating Gulf War Illness, by symptom domain ...
Confirmation of Diet as a Treatment for Gulf War IllnessImprovements were noted in every symptom domain and included significant reductions in overall symptom number (with an average of 9 symptoms going away), ...
Gulf War Illness: A Systematic Review of Therapeutic ...Mindfulness-based stress reduction improved pain, cognitive functioning, fatigue, depression, and posttraumatic stress disorder (PTSD), while.
Low glutamate diet as a potential therapy for headache in ...While prior research has shown improvements in headache symptoms with dietary interventions, there is limited evidence on diet-based treatments ...
A Systematic Review of Therapeutic Interventions and ...We conducted a systematic review to catalogue the types of treatments that have been examined for GWI, to evaluate the effectiveness and harms of these ...
A Detoxification Intervention for Gulf War IllnessWe reported feasibility and safety outcomes descriptively as frequencies or percentages. We summarized the descriptive data of symptoms and quality of life ...
New dietary intervention improves pain and other ...The veterans' overall number of symptoms were reduced and they experienced less pain and fatigue after one month on a diet low in glutamate, ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security